A Subgroup Analysis of the Impact of Prerandomization Antithrombin Therapy on Outcomes in the SYNERGY Trial Enoxaparin Versus Unfractionated Heparin in Non-ST-Segment Elevation Acute Coronary Syndromes.
Saved in:
| Title: | A Subgroup Analysis of the Impact of Prerandomization Antithrombin Therapy on Outcomes in the SYNERGY Trial Enoxaparin Versus Unfractionated Heparin in Non-ST-Segment Elevation Acute Coronary Syndromes. |
|---|---|
| Authors: | Cohen M (AUTHOR), Mahaffey KW (AUTHOR), Pieper K (AUTHOR), Pollack CV Jr (AUTHOR), Antman EM (AUTHOR), Hoekstra J (AUTHOR), Goodman SG (AUTHOR), Langer A (AUTHOR), Col JJ (AUTHOR), White HD (AUTHOR), Califf RM (AUTHOR), Ferguson JJ (AUTHOR), SYNERGY Trial Investigators (CORPORATE AUTHOR) |
| Source: | Journal of the American College of Cardiology (JACC). Oct2006, Vol. 48 Issue 7, p1346-1354. 9p. |
| Database: | Academic Search Ultimate |
Be the first to leave a comment!
